Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 14
2003 17
2004 8
2005 13
2006 10
2007 11
2008 18
2009 22
2010 18
2011 35
2012 25
2013 22
2014 15
2015 19
2016 16
2017 16
2018 14
2019 9
2020 12
2021 10
2022 9
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

302 results

Results by year

Filters applied: . Clear all
Page 1
Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy.
Sato T, Nagai M, Watanabe O, Misu T, Takenouchi N, Ohkubo R, Ishihara S, Tsuboi Y, Katsuno M, Nakagawa M, Matsushita T, Aso Y, Matsuura E, Tokashiki T, Mukaino A, Adachi H, Nakanishi K, Yamaguchi Y, Yamaguchi S, Yamano Y. Sato T, et al. Among authors: nakagawa m. J Neurol. 2024 Mar 2. doi: 10.1007/s00415-024-12239-x. Online ahead of print. J Neurol. 2024. PMID: 38430272
Polygenic effects on the risk of Alzheimer's disease in the Japanese population.
Kikuchi M, Miyashita A, Hara N, Kasuga K, Saito Y, Murayama S, Kakita A, Akatsu H, Ozaki K, Niida S, Kuwano R, Iwatsubo T, Nakaya A, Ikeuchi T; Alzheimer’s Disease Neuroimaging Initiative; Japanese Alzheimer’s Disease Neuroimaging Initiative. Kikuchi M, et al. Alzheimers Res Ther. 2024 Feb 27;16(1):45. doi: 10.1186/s13195-024-01414-x. Alzheimers Res Ther. 2024. PMID: 38414085 Free PMC article.
Anti-HTLV-1 immunity combined with proviral load as predictive biomarkers for adult T-cell leukemia-lymphoma.
Yamada A, Yasunaga JI, Liang L, Zhang W, Sunagawa J, Nakaoka S, Iwami S, Kogure Y, Ito Y, Kataoka K, Nakagawa M, Iwanaga M, Utsunomiya A, Koh KR, Watanabe T, Nosaka K, Matsuoka M. Yamada A, et al. Among authors: nakagawa m. Cancer Sci. 2024 Jan;115(1):310-320. doi: 10.1111/cas.15997. Epub 2023 Nov 10. Cancer Sci. 2024. PMID: 37950425 Free PMC article.
[Charcot-Marie-Tooth disease Patient Registry in Japan].
Okabe Y, Tsuji Y, Noto YI, Kitaoji T, Kojima Y, Kitani-Morii F, Mizuno T, Nakagawa M. Okabe Y, et al. Among authors: nakagawa m. Rinsho Shinkeigaku. 2023 Jun 28;63(6):350-358. doi: 10.5692/clinicalneurol.cn-001819. Epub 2023 May 17. Rinsho Shinkeigaku. 2023. PMID: 37197973 Japanese.
Different AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluid.
Kasuga K, Kikuchi M, Tsukie T, Suzuki K, Ihara R, Iwata A, Hara N, Miyashita A, Kuwano R, Iwatsubo T, Ikeuchi T; Japanese Alzheimer’s Disease Neuroimaging Initiative. Kasuga K, et al. BMJ Neurol Open. 2022 Aug 10;4(2):e000321. doi: 10.1136/bmjno-2022-000321. eCollection 2022. BMJ Neurol Open. 2022. PMID: 36046332 Free PMC article.
302 results